Aug 4 (Reuters) - New York City-based Pathos AI will pay $125 million upfront to a subsidiary of Alphamab Oncology for rights ...

Foundry utilizes thousands of AI agents working in parallel, powered by the Pathos Oncology Foundation Model. These agents analyze complex biological, clinical, and real-world data to intelligently ...

The DeepHealth Breast Ultrasound system automates the detection, characterisation, and reporting of breast lesions.

Thousands of women will participate in a study to see if AI could be used for early breast cancer detection. Around 700,000 women in the UK will take part in the AI breast cancer trial, according to ...

In a major breakthrough, a team of researchers from The City College of New York and Memorial Sloan Kettering Cancer Center (MSKCC) has developed a new AI model that can detect breast cancer in MRI ...

Pathos AI struck a deal for rights to a bispecific antibody drug conjugate from Alphamab that could become first in a new ...

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. Over the next 12 months, tens of thousands of women across ...

A Korean research team has reported that artificial intelligence (AI) used in mammography missed 14% of invasive breast cancers, the type where delayed diagnosis can directly impact patient survival.

A new study shows that AI can spot hidden signs in mammograms years before breast cancer develops, offering hope for tailored screening and earlier, life-saving action. Study: Artificial Intelligence ...

Breast Suite is an industry-leading, comprehensive, and modular AI-powered suite of applications supporting more than 10 million mammograms annually delivering increased breast cancer detection ...

Breast cancer is the most common cancer among women, with over 2.3 million new cases diagnosed each year. Traditional diagnostic methods rely heavily on human judgment, which can lead to inconsistent ...